A Phase 1 Open-label, Multicenter Study Evaluating the Safety and Efficacy of KITE-363 or KITE-753, Autologous Anti-CD19/CD20 CAR T-cell Therapies, in Subjects With Relapsed and/or Refractory B-cell Lymphoma Read more
Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells Read more
Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Loncastuximab: A Real World Multicenter Analysis Read more
A Phase 2 Study to Evaluate the Efficacy and Safety of MK-1026 in Participants with Hematologic Malignancies Read more
Outcomes of Current Front-Line Therapy Regimens in Elderly Patients with Classical Hodgkin’s Lymphoma Read more
Retrospective Analysis of intensive chemotherapy (modified Hyper-CVAD) in aggressive Non-Hodgkin Lymphoma patients – CNS outcomes Read more
Examining COVID19 course and outcomes in patients previously diagnosed with chronic lymphocytic leukemia (CLL) Read more
Molecular Profiling of Diffuse Large B Cell Lymphoma and Acute Leukemias Treated with Dose Intense Regimens Read more
